In this article, we will look at the 10 Best Growth Stocks to Buy With Huge Upside Potential.
On July 8, Tom Lee, head of research at Fundstrat, joined CNBC to discuss how the US tariffs might impact the market, economy, and inflation. The market seems to have digested the tariff episodes, and the current rally shows that the market doesn’t think that tariffs are going to cause turmoil. Lee noted that we now have enough data to infer that tariffs are not necessarily hurting the consumer’s wallet or job growth yet. However, we still need to wait and see its effect on inflation. Lee believes that the next inflation reports are important because if the tariff impact does not show up in upticking the core and consumer inflation, it will be good for the stock market.
Lee noted that the market is trying to keep a balance between the harsh statements coming from the White House to put pressure on closing deals and the practicality of these statements. Moreover, as the data shows that the policy is not impacting the economy as of yet, the White House is likely to continue with its tariff agenda, while ensuring that it does not derail the economy. Lee highlighted that while there are chances that volatility might increase, investors should keep the April 2nd scenario in mind, where the market rebounded in a V-shaped rally.
With that, let’s take a look at the 10 best growth stocks to buy with huge upside potential.
A graph monitoring stocks in a modern financial institution.
Our Methodology
To compile the list of 10 best growth stocks to buy with a huge upside potential, we used the Finviz stock screener and CNN as our sources. Using the screener, we aggregated a list of growth stocks with more than 40% upside potential. Next, we cross-checked the upside potential from CNN and ranked the stocks in ascending order of the number of hedge fund holders sourced from Insider Monkey’s Q1 2025 database. Please note that the data was recorded on July 7, 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
10 Best Growth Stocks to Buy With Huge Upside Potential
10. Genmab A/S (NASDAQ:GMAB)
Analyst Upside Potential: 50.64%
Number of Hedge Fund Holders: 20
Genmab A/S (NASDAQ:GMAB) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 15, Genmab A/S (NASDAQ:GMAB) announced results from its EPCORE NHL-2 trial, Arm 10. The study tested Epcoritamab, which is a bispecific antibody, in combination with R-ICE chemotherapy.
The study was focused on adult patients with relapsed or refractory diffuse large B-cell lymphoma who could undergo autologous stem cell transplantation. The results revealed that the combination therapy achieved an overall response rate of 87%. Moreover, 65% of patients had a complete response where no signs of cancer remained. On the other hand, 23% had a partial response.
The treatment was regarded as generally well-tolerated, and the most common side effects were low white blood cells, anemia, and low platelets. These results are promising for high-risk patients who need new options. The combination may help more patients reach a stem cell transplant, which can be curative. However, this therapy is still investigational and not yet approved for this use.
Genmab A/S (NASDAQ:GMAB) is a biotechnology company based in Denmark that develops antibody-based therapies for cancer and other diseases.
9. Cellebrite DI Ltd. (NASDAQ:CLBT)
Analyst Upside Potential: 53.87%
Number of Hedge Fund Holders: 30
Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 25, Cellebrite DI Ltd. (NASDAQ:CLBT) announced expanding its partnership with the National Center for Missing and Exploited Children (NCMEC) to help speed up investigations involving crimes against children.
A key part of this collaboration is the integration of NCMEC’s CyberTipline hash value list into Cellebrite DI Ltd. (NASDAQ:CLBT)’s main forensic software called the Cellebrite Inseyets. This list contains digital fingerprints, called hashes, of about 10 million files that have been confirmed as child sexual abuse material.
The integration allows investigators to instantly match files found on suspects’ devices to known CSAM. The integration is part of Cellebrite DI Ltd. (NASDAQ:CLBT)’s “Operation Find Them All” initiative. The program was launched in early 2024 and helps agencies use technology to rescue children and catch offenders.
Cellebrite DI Ltd. (NASDAQ:CLBT) is a software company that provides a Digital Intelligence platform designed to support legally sanctioned digital investigations.
